Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1

This integrative multistage study was aimed to identify circulating microRNAs (miRNAs) as prognostic biomarkers and investigate the treatment target for early-stage non-small cell lung cancer (NSCLC) patients. In stage I–II NSCLC patients, we screened and validated the miRNA ratio signatures predict...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Pharmacol Ther
Hlavní autoři: Zhang, Liren, Lin, Jing, Ye, Yuanqing, Oba, Taro, Gentile, Emanuela, Lian, Jie, Wang, Jing, Zhao, Yang, Gu, Jian, Wistuba, Ignacio I., Roth, Jack A., Ji, Lin, Wu, Xifeng
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893421/
https://ncbi.nlm.nih.gov/pubmed/28891208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.870
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky